Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
life sciences
national
national blog main
national top stories
new york top stories
novartis
roche
2
×
san francisco top stories
abeona therapeutics
accent therapeutics
achilles therapeutics
akouos
alder biopharmaceuticals
alexion pharmaceuticals
alnylam pharmaceuticals
alopecia areata
amarin
amgen
aridis pharmaceuticals
aristea therapeutics
autoimmune diseases
axitinib
bellus health
billy dunn
biogen
biotech ipos
bolt biotherapeutics
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bridgebio
bristol-myers squibb
cancer
cell therapy
cidara therapeutics
cigna
concert pharmaceuticals
What
drug
new
2
×
patients
2
×
advantages
approved
atrophy
bar
bio
brings
daily
evrysdi
expect
fda
friday
gamble
green
home
intended
lights
liquid
market
medco’s
medicine
mover
muscular
oral
payers
physicians
plan
pricing
risdiplam
roche
roundup
sets
spinal
therapy
type
ubiome
undone
vertex’s
Language
unset
Current search:
roche
×
patients
×
new
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
